<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02270840</url>
  </required_header>
  <id_info>
    <org_study_id>Budapest Upgrade CRT 009-4.1</org_study_id>
    <nct_id>NCT02270840</nct_id>
  </id_info>
  <brief_title>Budapest Upgrade CRT Study (Version 009-4.1)</brief_title>
  <official_title>Effect of Biventricular Upgrade on Left Ventricular Reverse Remodeling and Clinical Outcomes in Patient With Left Ventricular Dysfunction and Intermittent or Permanent Apical/Septal Right Ventricular Pacing (Budapest CRT Upgrade Study)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Semmelweis University Heart and Vascular Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>University of Rochester</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Sheba Medical Center</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Pharmahungary Group</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Semmelweis University Heart and Vascular Center</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Effect of biventricular upgrade on left ventricular reverse remodeling and clinical outcomes
      in patient in left ventricular dysfunction and intermittent or permanent apical/septal right
      ventricular pacing (Budapest CRT upgrade study)
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The aim of this study is to investigate the effect of upgrade to a CRT-D device on clinical
      and echocardiographic response at 12-month in patients with left ventricular dysfunction
      (LVEF ≤35%), symptomatic heart failure (NYHA II, III, IV-a), and intermittent or permanent
      right ventricular pacing with paced QRS complex ≥ 150 ms compared to continued therapy with a
      single or dual chamber pacemaker (PM) or ICD.

      Prospective, post-market, international multicenter randomized controlled trial.
    </textblock>
  </detailed_description>
  <overall_status>Enrolling by invitation</overall_status>
  <start_date>November 2014</start_date>
  <completion_date type="Anticipated">October 2018</completion_date>
  <primary_completion_date type="Anticipated">October 2018</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>A composite clinical and echocardiographic end point comprising the first occurrence of a non-fatal heart failure event, all-cause mortality, or &lt; 15% reduction in echocardiography determined LVESV from baseline to 12-month.</measure>
    <time_frame>12 months</time_frame>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">360</enrollment>
  <condition>Cardiomyopathy</condition>
  <arm_group>
    <arm_group_label>CRT-D</arm_group_label>
    <description>Patients currently implanted with a single or dual chamber pacemaker or ICD will be upgraded to CRT.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Only ICD</arm_group_label>
    <description>In the ICD arm, choosing single or dual chamber device is based upon the investigator's discretion.
Subjects meeting the inclusion criteria (and if exclusion criteria are not present) patients will be randomized to CRT-D upgrade or ICD only (either continued ICD therapy in patients currently implanted with a defibrillator or implantation of a defibrillator in eligible patients who are currently implanted with pacemaker-only).</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>CRT-D</intervention_name>
    <description>Biventricular upgrade. Subjects meeting the inclusion criteria (and if exclusion criteria are not present) patients will be randomized to CRT-D upgrade or ICD only (either continued ICD therapy in patients currently implanted with a defibrillator or implantation of a defibrillator in eligible patients who are currently implanted with pacemaker-only).</description>
    <arm_group_label>CRT-D</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Altogether 360 subjects will be enrolled at the European and Israeli study sites,
        randomized in the rate of 3:2 (CRT-D:ICD groups).
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Male or female patients over the age of 18 (expected survival time: over 1 year)

          -  Patients with ischemic or non-ischemic cardiomyopathy;

          -  Those implanted with a single or dual chamber ICD or implanted with a single or dual
             chamber pacemaker at least 6 months before inclusion;

          -  Elective generator replacement or upgrade from pacemaker-only to ICD therapy may be
             indicated at the time of enrollment, but are not required;

          -  Right ventricular pacing 20-100% in at least the last 90 days before enrollment (with
             an optimal AV interval based on the physician's discretion to avoid unnecessary right
             ventricular stimulation);

          -  Symptomatic heart failure for at least 3 months before inclusion;

          -  NYHA functional class II or III, or IV a;

          -  Left ventricular ejection fraction measured by echocardiography ≤ 35%;

          -  Paced QRS complex ≥ 150 ms;

          -  Optimal heart failure medical therapy;

          -  Informed consent obtained.

        Exclusion Criteria:

          -  Intrinsic QRS with LBBB morphology (measured at VVI 40 bpm setting as per protocol);

          -  CABG or PCI in the past 3 months;

          -  Acute myocardial infarction in the past 3 months;

          -  Unstable angina;

          -  Planned coronary revascularization (PCI or CABG);

          -  Planned cardiac transplantation;

          -  Acute myocarditis;

          -  Infiltrative myocardial disease;

          -  Hypertrophic cardiomyopathy;

          -  Severe primary mitral and aortic valve stenosis or regurgitation;

          -  Women who are pregnant or plan to become pregnant or breastfeeding;

          -  Subjects who are unable or unwilling to cooperate with the study protocol;

          -  Tricuspid valve prosthesis;

          -  Any serious disease likely to interfere with the conduct of the study;

          -  Participation in other clinical trial;

          -  Patients geographically not stable or unavailable for follow-up;

          -  Chronic, severe renal dysfunction (creatinine value &gt; 200 μmol/l);

          -  Severe RV dilatation (RV basal diameter &gt;50mm);

          -  Severe tricuspid insufficiency.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Valentina Kutyifa, MD</last_name>
    <role>Study Director</role>
    <affiliation>University of Rochester Medical Center, Rochester, NY, USA</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Ilan Goldenberg, Prof. MD</last_name>
    <role>Study Director</role>
    <affiliation>Sheba Medical Center Tel-Hashomer, Israel</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Béla Merkely, Prof. MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Semmelweis University Hearth and Vascular Center, Budapest, Hungary</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Annamaria Kosztin, MD</last_name>
    <role>Study Director</role>
    <affiliation>Semmelweis University Hearth and Vascular Center, Budapest, Hungary</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>IK+EM Clinic of Cardiology</name>
      <address>
        <city>Praha</city>
        <zip>14021</zip>
        <country>Czechia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Asklepios Clinic St. Georg</name>
      <address>
        <city>Hamburg</city>
        <zip>20099</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hannover Medical School</name>
      <address>
        <city>Hannover</city>
        <zip>30625</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Herzzentrum Leipzig GmbH</name>
      <address>
        <city>Leipzig</city>
        <zip>04289</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Second Department of Internal Medicine and Cardiology Center, Faculty of Medicine, University of Szeged</name>
      <address>
        <city>Szeged</city>
        <state>Csongrád</state>
        <zip>6725</zip>
        <country>Hungary</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Institute of Cardiology University of Debrecen</name>
      <address>
        <city>Debrecen</city>
        <state>Hajdú-Bihar</state>
        <zip>4032</zip>
        <country>Hungary</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hungarian Institute of Cardiology</name>
      <address>
        <city>Budapest</city>
        <zip>1096</zip>
        <country>Hungary</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Semmelweis University Heart and Vascular Center</name>
      <address>
        <city>Budapest</city>
        <zip>1122</zip>
        <country>Hungary</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Depratment of Cardiology, Military Hospital, Hungarian Army Medical Center</name>
      <address>
        <city>Budapest</city>
        <zip>1134</zip>
        <country>Hungary</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Pécs Medical School, Heart Institute</name>
      <address>
        <city>Pécs</city>
        <zip>7624</zip>
        <country>Hungary</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Barzilai Medical Center</name>
      <address>
        <city>Ashkelon</city>
        <zip>78278</zip>
        <country>Israel</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Kaplan Medical Center</name>
      <address>
        <city>Rehovot</city>
        <zip>76100</zip>
        <country>Israel</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Central Clinical Hospital of Silesia, Department of Electrocardiology</name>
      <address>
        <city>Katowice</city>
        <zip>40-055</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Górnośląski Ośrodek Kardiologii</name>
      <address>
        <city>Katowice</city>
        <zip>40-629</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Department of Interventional Cardiology, Medical University of Lodz,</name>
      <address>
        <city>Lodz</city>
        <zip>90-549</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>MC-Tronik</name>
      <address>
        <city>Lodz</city>
        <zip>90-553</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Cardinal Stefan Wyszynski Institute of Cardiology</name>
      <address>
        <city>Warsaw</city>
        <zip>04-628</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Coronary Artery Disease II. Dept. Institute of Cardiology</name>
      <address>
        <city>Warsaw</city>
        <zip>04-628</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Bieganski Specialty Regional Hospital, Dept. of Cardiology</name>
      <address>
        <city>Łódź</city>
        <zip>91-347</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Research Institute of Blood Circulation Pathology</name>
      <address>
        <city>Novosibirsk</city>
        <zip>630055</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Institute of Cardiology, Siberian Branch, Russian Academy of Medical Sciences</name>
      <address>
        <city>Novosibirsk</city>
        <zip>630090</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Clinical Center of Serbia</name>
      <address>
        <city>Belgrade</city>
        <zip>11000</zip>
        <country>Serbia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University Medical Center Ljubljana</name>
      <address>
        <city>Ljubljana</city>
        <zip>SI-1000</zip>
        <country>Slovenia</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Czechia</country>
    <country>Germany</country>
    <country>Hungary</country>
    <country>Israel</country>
    <country>Poland</country>
    <country>Russian Federation</country>
    <country>Serbia</country>
    <country>Slovenia</country>
  </location_countries>
  <removed_countries>
    <country>Czech Republic</country>
  </removed_countries>
  <verification_date>November 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 17, 2014</study_first_submitted>
  <study_first_submitted_qc>October 20, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 21, 2014</study_first_posted>
  <last_update_submitted>November 7, 2017</last_update_submitted>
  <last_update_submitted_qc>November 7, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">November 8, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>cardiac resynchronization therapy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cardiomyopathies</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

